Vistin Pharma ASA (VISTN) — Working Capital to Net Assets Ratio
Vistin Pharma ASA (VISTN) has a Working Capital to Net Assets ratio of 41.1% as of March 2026. Working capital of Nkr144.02 Million (current assets of Nkr217.54 Million minus current liabilities of Nkr73.52 Million) is measured against net assets of Nkr350.31 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See VISTN defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Vistin Pharma ASA Working Capital to Net Assets (2016–2025)
This chart shows how Vistin Pharma ASA's Working Capital to Net Assets ratio has evolved across 10 annual periods from 2016 to 2025. As of March 2026, the ratio stands at 41.1%, reflecting working capital of Nkr144.02 Million against net assets of Nkr350.31 Million NOK. For the complete balance sheet picture, see total assets of Vistin Pharma ASA.
Annual Working Capital to Net Assets for Vistin Pharma ASA (2016–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Vistin Pharma ASA from 2016 to 2025, covering 10 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check asset resilience ratio of Vistin Pharma ASA to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (NOK) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 35.5% | Nkr116.80 Million | Nkr328.81 Million | Nkr203.52 Million | Nkr86.72 Million | ▲ +9.9 pp |
| 2024 | 25.6% | Nkr79.22 Million | Nkr309.53 Million | Nkr143.19 Million | Nkr63.97 Million | ▼ -5.2 pp |
| 2023 | 30.8% | Nkr99.30 Million | Nkr322.77 Million | Nkr168.77 Million | Nkr69.47 Million | ▲ +15.2 pp |
| 2022 | 15.5% | Nkr42.44 Million | Nkr273.26 Million | Nkr154.11 Million | Nkr111.67 Million | ▼ -19.6 pp |
| 2021 | 35.1% | Nkr96.80 Million | Nkr275.89 Million | Nkr137.83 Million | Nkr41.03 Million | ▼ -5.0 pp |
| 2020 | 40.1% | Nkr109.32 Million | Nkr272.40 Million | Nkr141.53 Million | Nkr32.20 Million | ▼ -37.6 pp |
| 2019 | 77.7% | Nkr321.39 Million | Nkr413.40 Million | Nkr394.63 Million | Nkr73.24 Million | ▲ +4.7 pp |
| 2018 | 73.1% | Nkr254.96 Million | Nkr348.85 Million | Nkr389.29 Million | Nkr134.33 Million | ▲ +20.5 pp |
| 2017 | 52.6% | Nkr63.21 Million | Nkr120.16 Million | Nkr160.06 Million | Nkr96.85 Million | ▼ -25.3 pp |
| 2016 | 77.9% | Nkr145.35 Million | Nkr186.61 Million | Nkr225.97 Million | Nkr80.62 Million | — |